Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisanori Suzuki

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Clinical Calcium|September 4, 2013
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs]Hisanori Suzuki
Clinical Calcium|October 28, 2015
[Bone complications in chronic liver disease(hepatic osteodystrophy)]Hisanori Suzuki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Instruction on the use of drugs to an osteoporosis curative medicine]Takanori Miura, Hisanori Suzuki
Clinical Calcium|February 29, 2012
[Combination or sequential treatment using PTH and anti-resorption therapies]Hisanori Suzuki, Yasuhiro Takeuchi
Clinical Calcium|October 1, 2013
[Updates on rickets and osteomalacia: etiology and pathophysiology of osteomalacia]Hisanori Suzuki, Yasuhiro Takeuchi
Current Pharmaceutical Design|May 12, 2004
Biochemical aspects of nitric oxideSofia Mariotto, Marta Menegazzi, Hisanori Suzuki
Critical Care Medicine|May 29, 2003
Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemiaTiziana Bachetti, Evasio Pasini, Hisanori Suzuki, et al.
Antioxidants & Redox Signaling|June 15, 2006
Cross-talk between constitutive and inducible NO synthase: an updateTiziana Persichini, Orazio Cantoni, Hisanori Suzuki, et al.
Genes & Nutrition|October 14, 2008
Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoidElena Darra, Kazuo Shoji, Sofia Mariotto, et al.
Neuroscience Letters|September 27, 2005
Regulation of serine racemase activity by D-serine and nitric oxide in human glioblastoma cellsKazuo Shoji, Sofia Mariotto, Anna Rosa Ciampa, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Clinical Calcium|September 4, 2013
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs]Hisanori Suzuki
Clinical Calcium|October 28, 2015
[Bone complications in chronic liver disease(hepatic osteodystrophy)]Hisanori Suzuki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Instruction on the use of drugs to an osteoporosis curative medicine]Takanori Miura, Hisanori Suzuki
Clinical Calcium|February 29, 2012
[Combination or sequential treatment using PTH and anti-resorption therapies]Hisanori Suzuki, Yasuhiro Takeuchi
Clinical Calcium|October 1, 2013
[Updates on rickets and osteomalacia: etiology and pathophysiology of osteomalacia]Hisanori Suzuki, Yasuhiro Takeuchi
Current Pharmaceutical Design|May 12, 2004
Biochemical aspects of nitric oxideSofia Mariotto, Marta Menegazzi, Hisanori Suzuki
Critical Care Medicine|May 29, 2003
Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemiaTiziana Bachetti, Evasio Pasini, Hisanori Suzuki, et al.
Antioxidants & Redox Signaling|June 15, 2006
Cross-talk between constitutive and inducible NO synthase: an updateTiziana Persichini, Orazio Cantoni, Hisanori Suzuki, et al.
Genes & Nutrition|October 14, 2008
Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoidElena Darra, Kazuo Shoji, Sofia Mariotto, et al.
Neuroscience Letters|September 27, 2005
Regulation of serine racemase activity by D-serine and nitric oxide in human glioblastoma cellsKazuo Shoji, Sofia Mariotto, Anna Rosa Ciampa, et al.
Pageof 9